| Announce Date | 11/14/2025 |
| EPS Normalized Actual | $0.37 (Beat by $0.04) |
| EPS GAAP Actual | $0.37 (Beat by $0.04) |
| Revenue Actual | $3780.72B |
| Revenue Surprise | Beat by $3780720M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $3268.0030115B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2031 | 262.39104 | 0.09 | 245.62591 | 292.7212 | 1 |
| Mar 2030 | 202.13909 | 0.11 | 185.86369 | 240.31614 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -172.08 | -172.08 | 3780.72B | -16.63% | -203637.39M |
| FQ3 2025 (Sep 2025) | 60.48 | 60.48 | 3107.91B | 6.51% | 3107910M |
| FQ1 2025 (Mar 2025) | 32.76 | 32.76 | 2630.24B | -32.34% | 2630240M |
| FQ2 2025 (Jun 2025) | 39.4 | 39.4 | 2621.62B | -14.88% | 2621620M |
| FQ4 2024 (Dec 2024) | 61.54 | 61.54 | 4409.57B | 15.01% | 4409570M |
| FQ3 2024 (Sep 2024) | 55.363 | 55.363 | 2905.6B | 2.65% | 2905600M |
| FQ2 2024 (Jun 2024) | 189.9 | 189.9 | 3011.65B | 1.59% | 3011650M |
| FQ1 2024 (Mar 2024) | 154.12 | 154.12 | 3480.97B | 11.99% | 3480970M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
3268.0030115B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2029 (Mar 2029) | 46.18548 | -- | 43.60784 | 52.65414 | 1 |
| FQ4 2028 (Dec 2028) | 59.15609 | -- | 55.85455 | 67.44139 | 1 |
| FQ3 2028 (Sep 2028) | 50.73825 | -- | 47.90651 | 57.84456 | 1 |
| FQ2 2028 (Jun 2028) | 35.76525 | -- | 33.76917 | 40.77447 | 1 |
| FQ1 2028 (Mar 2028) | 46.18548 | -- | 42.1667 | 52.73083 | 1 |
| FQ4 2027 (Dec 2027) | 59.15609 | -- | 54.00869 | 67.53962 | 1 |
| FQ3 2027 (Sep 2027) | 50.73825 | -- | 46.32332 | 57.92881 | 1 |
| FQ2 2027 (Jun 2027) | 35.76525 | -- | 32.65318 | 40.83386 | 1 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | 0 | INF | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2029 (Mar 2029) | 3129.3B | -- | 2994.96B | 3466.44B | 4 |
| FQ4 2028 (Dec 2028) | 3968.44B | -- | 3798.07B | 4395.99B | 3 |
| FQ3 2028 (Sep 2028) | 3371.38B | -- | 3226.64B | 3734.6B | 5 |
| FQ2 2028 (Jun 2028) | 2716.74B | -- | 2600.11B | 3009.43B | 3 |
| FQ1 2028 (Mar 2028) | 3663.78B | -- | 3418.55B | 4063.18B | 2 |
| FQ4 2027 (Dec 2027) | 3721.24B | -- | 3472.17B | 4126.91B | 3 |
| FQ3 2027 (Sep 2027) | 3379.78B | -- | 3153.56B | 3748.22B | 3 |
| FQ2 2027 (Jun 2027) | 2476.31B | -- | 2310.56B | 2746.26B | 3 |
| FQ1 2027 (Mar 2027) | 3501.99B | -- | 3501.99B | 3501.99B | 0 |
| FQ4 2026 (Dec 2026) | 4132.73B | 8.52 | 4132.73B | 4132.73B | 0 |
| FQ3 2026 (Sep 2026) | 3065.95B | -1.37 | 3065.95B | 3065.95B | 0 |
| FQ2 2026 (Jun 2026) | 2818.09B | 6.97 | 2818.09B | 2818.09B | 0 |
| FQ1 2026 (Mar 2026) | 3268B | 19.52 | 3268B | 3268B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0 | -172.08 | -172.08 | 100% |
| FQ3 2025 (Sep 2025) | 60.48 | 60.48 | 100% | |
| FQ1 2025 (Mar 2025) | 32.76 | 32.76 | 100% | |
| FQ2 2025 (Jun 2025) | 39.4 | 39.4 | 100% | |
| FQ4 2024 (Dec 2024) | 61.54 | 61.54 | 100% | |
| FQ3 2024 (Sep 2024) | 55.363 | 55.363 | 100% | |
| FQ2 2024 (Jun 2024) | 189.9 | 189.9 | 100% | |
| FQ1 2024 (Mar 2024) | 154.12 | 154.12 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $3984.36B | $3780.72B | $-203637.39M | -5.39% |
| FQ3 2025 (Sep 2025) | $0B | $3107.91B | $3107910M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2630.24B | $2630240M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2621.62B | $2621620M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $4409.57B | $4409570M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2905.6B | $2905600M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3011.65B | $3011650M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3480.97B | $3480970M | 100% |